SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gliatech (GLIA)
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
2001 20 0 GLIA
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
951 Gue, I agree. I feel GLIA will be at least $31 in six months not $20 in 12 montJack Hartmann-9/28/1999
950 Just read the report. They have a 12-month price target of $20. Not exactly gogue-9/28/1999
949 The report is available at stephens.com Hit "Accept Agreement and Go To Hgue-9/28/1999
948 Flash: 09/28 8:56A (DJ) *DJ Stephens Inc. Starts Gliatech At Outperform No otPHILLIP FLOTOW-9/28/1999
947 Jim: I'll copy your post and send it to IR at GLIA. Thanks for the pointescaram(o)uche-9/27/1999
946 How is this glycine transporter program impacted by the patent that Trophix (boBiotech Jim-9/27/1999
945 <i>Gliatech has initiated drug development programs aimed at developing nscaram(o)uche-9/27/1999
944 Gliatech Announces Product Development Program for Schizophrenia Monday SeptemM. P. McNamara, Jr. M.D.-9/27/1999
943 <Gliatech being punished solely for being so small. > And for being a &#LLCF-9/26/1999
942 Gliatech is now 46% off it's High for the Year and only 10% above it'sAsymmetric-9/26/1999
941 <I like the stock because earnings are supposed to jump year to year. (.50)LLCF-9/24/1999
940 I like the stock because earnings are supposed to jump year to year. (.50) lastJack Hartmann-9/24/1999
939 Stock drives me nuts. I'm still very enthusiastic about them, but I donscaram(o)uche-9/23/1999
938 What puzzles me about GLIA is what is it about the company which makes it so iW PAUL-9/23/1999
937 Frost and Sullivan Award to GLIA CLEVELAND, Sept. 21 /PRNewswire/ -- Gliatech IJack Hartmann-9/21/1999
936 Dr. Harmon - I won't pontificate on the boards again if it's unwanted. Jesse Schulman-9/8/1999
935 itss: Are you going to visit every biotech thread at SI and, for those that yoscaram(o)uche-9/7/1999
934 Rick - Thanks much for the info. For now I'm going to ponder on the sideliJesse Schulman-9/7/1999
933 RCMac - Yes, thanks a lot, very helpful indeed. Didn't mean to sound like aJesse Schulman-9/7/1999
932 ITSS, Although you've "read the thread" etc., there's a loRCMac-9/7/1999
931 H3 (GT 2331) has completed multi-dose phase I, and the company has budgeted a pscaram(o)uche-9/7/1999
930 RH, DAK and others - hello - at the risk of sounding like the rookie I am, can Jesse Schulman-9/7/1999
929 Rick, Followup to your Yahoo followup. I ran the same medline searches by authAbuckatatime-9/4/1999
928 just to let everyone know..... there has been some discussion on the Yahoo thscaram(o)uche-9/4/1999
927 Jim: The molecules, to my knowledge, are derivatives of naturally occurring agscaram(o)uche-9/1/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News